These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 16267356)
1. Corticosteroids: potential beta2-agonist and anticholinergic interactions in chronic obstructive pulmonary disease. Johnson M Proc Am Thorac Soc; 2005; 2(4):320-5; discussion 340-1. PubMed ID: 16267356 [TBL] [Abstract][Full Text] [Related]
2. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases. Sin DD; Man SF Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807 [TBL] [Abstract][Full Text] [Related]
3. Interactions between corticosteroids and beta2-agonists in asthma and chronic obstructive pulmonary disease. Johnson M Proc Am Thorac Soc; 2004; 1(3):200-6. PubMed ID: 16113435 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis. Baker WL; Baker EL; Coleman CI Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942 [TBL] [Abstract][Full Text] [Related]
6. [Other forms of bronchodilation]. Izquierdo Alonso JL; Malo de Molina R Arch Bronconeumol; 2004 Mar; 40 Suppl 1():23-9. PubMed ID: 16137446 [No Abstract] [Full Text] [Related]
7. Optimizing treatment of chronic obstructive pulmonary disease: an assessment of current therapies. Wise RA; Tashkin DP Am J Med; 2007 Aug; 120(8 Suppl 1):S4-13. PubMed ID: 17678942 [TBL] [Abstract][Full Text] [Related]
9. Achieving therapeutic benefits of inhaled corticosteroids/beta2 agonist in chronic obstructive airway disease. Wang ZL Chin Med J (Engl); 2007 Jun; 120(12):1097-105. PubMed ID: 17637229 [No Abstract] [Full Text] [Related]
10. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD. Ohar JA; Donohue JF Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301 [TBL] [Abstract][Full Text] [Related]
11. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes. Hanania NA Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470 [TBL] [Abstract][Full Text] [Related]
12. Distribution of receptor targets in the lung. Barnes PJ Proc Am Thorac Soc; 2004; 1(4):345-51. PubMed ID: 16113456 [TBL] [Abstract][Full Text] [Related]
13. Combination therapy of inhaled corticosteroids and long-acting beta2-adrenergics in management of patients with chronic obstructive pulmonary disease. Sin DD; Johnson M; Gan WQ; Man SF Curr Pharm Des; 2004; 10(28):3547-60. PubMed ID: 15579052 [TBL] [Abstract][Full Text] [Related]
15. Can β2-adrenoceptor agonists, anticholinergic drugs, and theophylline contribute to the control of pulmonary inflammation and emphysema in COPD? Zhang WH; Zhang Y; Cui YY; Rong WF; Cambier C; Devillier P; Bureau F; Advenier C; Gustin P Fundam Clin Pharmacol; 2012 Feb; 26(1):118-34. PubMed ID: 22044554 [TBL] [Abstract][Full Text] [Related]
16. Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease. Belmonte KE Proc Am Thorac Soc; 2005; 2(4):297-304; discussion 311-2. PubMed ID: 16267352 [TBL] [Abstract][Full Text] [Related]
17. [New drug therapy of chronic obstructive pulmonary disease]. Kino H Nihon Rinsho; 2003 Dec; 61(12):2175-80. PubMed ID: 14674329 [TBL] [Abstract][Full Text] [Related]
18. Research and development of bronchodilators for asthma and COPD with a focus on G protein/KCa channel linkage and β2-adrenergic intrinsic efficacy. Kume H; Fukunaga K; Oguma T Pharmacol Ther; 2015 Dec; 156():75-89. PubMed ID: 26432616 [TBL] [Abstract][Full Text] [Related]